Le Lézard
Classified in: Health

Healogics Joins the Epic App Orchard


JACKSONVILLE, Fla., Sept. 25, 2018 /PRNewswire/ -- Healogics Inc., the nation's largest provider of advanced wound care services, today announced they have joined the App Orchard to begin working on an integration to improve interoperability within their nationwide network of Wound Care Centers®. Currently, this integration is set to deploy in the fall of 2019.

Healogics, Inc: The foremost advanced wound care services provider for hospitals. (PRNewsfoto/Healogics, Inc.)

This integration will allow discrete data flow between systems with a goal to reduce errors for hospital compliance and audits, eliminate redundant double entry work for Wound Care Centers and foster better partnerships with hospital systems. Additionally, these updates will allow for integration with Healogics applications, and Epic creating a more streamlined user experience.

"This integration is a major step forward for Healogics' hospital partners that are looking to use Epic in their Wound Care Center," said Ty Smith, Chief Information Officer at Healogics. "This level of integration will bring the best of Healogics applications into the Epic ecosystem and supports our Centers with the best technology available. We are looking forward to all the ways in which these updates will improve the patient experience and save time for clinicians and physicians, all while increasing the quality and consistency of patient care."

About Healogics 
Headquartered in Jacksonville, Fla., Healogics is the nation's wound healing expert. Last year over 330,000 patients received advanced wound care through a nationwide network of nearly 700 Wound Care Centers®.  The Healogics team is made up of almost 3,000 employees, 4,000 affiliated physicians and a Healogics Specialty Physician practice group of nearly 300. In addition to the company's network of outpatient Centers, Healogics partners with over 300 skilled nursing facilities to care for patients with chronic wounds, and provides inpatient consults at more than 80 partner hospitals. As the industry leader, Healogics has the largest repository of chronic wound-specific patient data in the country. The Healogics Wound Science Initiative, an effort launched in 2017 to provide peer-reviewed research, recognizes the value and relevance of big data and advanced analytics to drive continuous, collaborative learning towards a better understanding of how to efficiently utilize healthcare resources for patients with wounds. For additional information, please visit Healogics.com.

 

 

 

SOURCE Healogics, Inc.


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: